Effects of schizophrenia risk variation in the NRG1 gene on NRG1-IV splicing during fetal and early postnatal human neocortical development

American Journal of Psychiatry

Volumn 171, Issue 9, 2014, Pages 979-989

  Paterson, Clare ^a   Wang, Yanhong ^a   Kleinman, Joel E ^a   Law, Amanda J ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; NEU DIFFERENTIATION FACTOR; ISOPROTEIN; NRG1 PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; BETA ACTIN GENE; BRAIN DEVELOPMENT; CELLULAR DISTRIBUTION; CHILD; CONTROLLED STUDY; FEMALE; FETUS; GAPDH GENE; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC REGULATION; GENETIC RISK; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MALE; NRG1 GENE; NUCLEOTIDE SEQUENCE; PBGD GENE; POSTNATAL DEVELOPMENT; PREFRONTAL CORTEX; PREGNANCY; PRENATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROCESSING; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RNA SPLICING; SCHIZOPHRENIA; ALTERNATIVE RNA SPLICING; AUTOPSY; CHEMISTRY; GENETIC PREDISPOSITION; GENETICS; GESTATIONAL AGE; GROWTH, DEVELOPMENT AND AGING; METABOLISM; NERVOUS SYSTEM DEVELOPMENT; PATHOLOGY; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALTERNATIVE SPLICING; AUTOPSY; FEMALE; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; GESTATIONAL AGE; HUMANS; MALE; NEUREGULIN-1; NEUROGENESIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREFRONTAL CORTEX; PROTEIN ISOFORMS; RISK FACTORS; SCHIZOPHRENIA;

EID: 84921665900     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2014.13111518     Document Type: Article

References (51)

1. Falls DL: Neuregulins: functions, forms, and signaling strategies. Exp Cell Res 2003; 284:14-30
2. Steinthorsdottir V, Stefansson H, Ghosh S, Birgisdottir B, Bjornsdottir S, Fasquel AC, Olafsson O, Stefansson K, Gulcher JR: Multiple novel transcription initiation sites for NRG1. Gene 2004; 342:97-105 (Pubitemid 39457182)
3. Mei L, Xiong WC: Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat Rev Neurosci 2008; 9:437-452 (Pubitemid 351704944)
4. Liu X, Bates R, Yin DM, Shen C, Wang F, Su N, Kirov SA, Luo Y, Wang JZ, Xiong WC, Mei L: Specific regulation of NRG1 isoform expression by neuronal activity. J Neurosci 2011; 31:8491-8501
5. Deakin IH, Law AJ, Oliver PL, Schwab MH, Nave KA, Harrison PJ, Bannerman DM: Behavioural characterization of neuregulin 1 type I overexpressing transgenic mice. Neuroreport 2009; 20:1523-1528
6. Wen L, Lu YS, Zhu XH, Li XM, Woo RS, Chen YJ, Yin DM, Lai C, Terry AV Jr, Vazdarjanova A, Xiong WC, Mei L: Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbuminpositive interneurons. Proc Natl Acad Sci USA 2010; 107:1211-1216
7. Fazzari P, Paternain AV, Valiente M, Pla R, Luján R, Lloyd K, Lerma J, Marín O, Rico B: Control of cortical GABA circuitry development by Nrg1 and ErbB4 signalling. Nature 2010; 464:1376-1380
8. Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, Ghosh S, Brynjolfsson J, Gunnarsdottir S, Ivarsson O, Chou TT, Hjaltason O, Birgisdottir B, Jonsson H, Gudnadottir VG, Gudmundsdottir E, Bjornsson A, Ingvarsson B, Ingason A, Sigfusson S, Hardardottir H, Harvey RP, Lai D, Zhou M, Brunner D, Mutel V, Gonzalo A, Lemke G, Sainz J, Johannesson G, Andresson T, Gudbjartsson D, Manolescu A, Frigge ML, Gurney ME, Kong A, Gulcher JR, Petursson H, Stefansson K: Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 2002; 71:877-892 (Pubitemid 135750519)
9. Stefansson H, Sarginson J, Kong A, Yates P, Steinthorsdottir V, Gudfinnsson E, Gunnarsdottir S, Walker N, Petursson H, Crombie C, Ingason A, Gulcher JR, Stefansson K, St Clair D: Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. Am J Hum Genet 2003; 72:83-87 (Pubitemid 36056844)
10. Corvin AP, Morris DW, McGhee K, Schwaiger S, Scully P, Quinn J, Meagher D, St Clair D, Waddington JL, Gill M: Confirmation and refinement of an ' at-risk ' haplotype for schizophrenia suggests the EST cluster, Hs.97362, as a potential susceptibility gene at the Neuregulin-1 locus. Mol Psychiatry 2004; 9:208-213
11. Kukshal P, Bhatia T, Bhagwat AM, Gur RE, Gur RC, Deshpande SN, Nimgaonkar VL, Thelma BK: Association study of neuregulin-1 gene polymorphisms in a North Indian schizophrenia sample. Schizophr Res 2013; 144:24-30
12. Thomson PA, Christoforou A, Morris SW, Adie E, Pickard BS, Porteous DJ, Muir WJ, Blackwood DH, Evans KL: Association of Neuregulin 1 with schizophrenia and bipolar disorder in a second cohort from the Scottish population. Mol Psychiatry 2007; 12:94-104 (Pubitemid 44973666)
13. Walker RM, Christoforou A, Thomson PA, McGhee KA, Maclean A, Mühleisen TW, Strohmaier J, Nieratschker V, Nöthen MM, Rietschel M, Cichon S, Morris SW, Jilani O, St Clair D, Blackwood DH, Muir WJ, Porteous DJ, Evans KL: Association analysis of Neuregulin 1 candidate regions in schizophrenia and bipolar disorder. Neurosci Lett 2010; 478:9-13
14. Stefánsson H, Thorgeirsson TE, Gulcher JR, Stefánsson K: Neuregulin 1 in schizophrenia: out of Iceland. Mol Psychiatry 2003; 8:639-640
15. Harrison PJ, Law AJ: Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology. Biol Psychiatry 2006; 60:132-140
16. Munafò MR, Thiselton DL, Clark TG, Flint J: Association of the NRG1 gene and schizophrenia: a meta-analysis. Mol Psychiatry 2006; 11:539-546
17. Li D, Collier DA, He L: Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia. Hum Mol Genet 2006; 15:1995-2002 (Pubitemid 43983273)
18. Agim ZS, Esendal M, Briollais L, Uyan O, Meschian M, Martinez LA, Ding Y, Basak AN, Ozcelik H: Discovery, validation and characterization of Erbb4 and Nrg1 haplotypes using data from three genome-wide association studies of schizophrenia. PLoS ONE 2013; 8:e53042
19. Tan W, Wang Y, Gold B, Chen J, Dean M, Harrison PJ, Weinberger DR, Law AJ: Molecular cloning of a brain-specific, developmentally regulated neuregulin 1 (NRG1) isoform and identification of a functional promoter variant associated with schizophrenia. J Biol Chem 2007; 282:24343-24351 (Pubitemid 47328000)
20. Law AJ, Lipska BK, Weickert CS, Hyde TM, Straub RE, Hashimoto R, Harrison PJ, Kleinman JE, Weinberger DR: Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5: SNPs associated with the disease. Proc Natl Acad Sci USA 2006; 103:6747-6752
21. Moon E, Rollins B, Mesén A, Sequeira A, Myers RM, Akil H, Watson SJ, Barchas J, Jones EG, Schatzberg A, Bunney WE, DeLisi LE, Byerley W, Vawter MP: Lack of association to a NRG1 missense polymorphism in schizophrenia or bipolar disorder in a Costa Rican population. Schizophr Res 2011; 131:52-57
22. Hall J, Whalley HC, Job DE, Baig BJ, McIntosh AM, Evans KL, Thomson PA, Porteous DJ, Cunningham-Owens DG, Johnstone EC, Lawrie SM: A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms. Nat Neurosci 2006; 9:1477-1478 (Pubitemid 44862654)
23. Stefanis NC, Trikalinos TA, Avramopoulos D, Smyrnis N, Evdokimidis I, Ntzani EE, Ioannidis JP, Stefanis CN: Impact of schizophrenia candidate genes on schizotypy and cognitive endophenotypes at the population level. Biol Psychiatry 2007; 62:784-792 (Pubitemid 47374644)
24. McIntosh AM, Moorhead TW, Job D, Lymer GK, Muñoz Maniega S, McKirdy J, Sussmann JE, Baig BJ, Bastin ME, Porteous D, Evans KL, Johnstone EC, Lawrie SM, Hall J: The effects of a neuregulin 1 variant on white matter density and integrity. Mol Psychiatry 2008; 13:1054-1059
25. Mata I, Perez-Iglesias R, Roiz-Santiañez R, Tordesillas-Gutierrez D, Gonzalez-Mandly A, Berja A, Vazquez-Barquero JL, Crespo-Facorro B: Additive effect of NRG1 and DISC1 genes on lateral ventricle enlargement in first episode schizophrenia. Neuroimage 2010; 53:1016-1022
26. Roussos P, Giakoumaki SG, Adamaki E, Bitsios P: The influence of schizophrenia-related neuregulin-1 polymorphisms on sensorimotor gating in healthy males. Biol Psychiatry 2011; 69:479-486
27. Knickmeyer RC, Wang J, Zhu H, Geng X, Woolson S, Hamer RM, Konneker T, Lin W, Styner M, Gilmore JH: Common variants in psychiatric risk genes predict brain structure at birth. Cereb Cortex 2014; 24:1230-1246
28. Kleinman JE, Law AJ, Lipska BK, Hyde TM, Ellis JK, Harrison PJ, Weinberger DR: Genetic neuropathology of schizophrenia: new approaches to an old question and new uses for postmortem human brains. Biol Psychiatry 2011; 69:140-145
29. Xu B, Ionita-Laza I, Roos JL, Boone B, Woodrick S, Sun Y, Levy S, Gogos JA, Karayiorgou M: De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia. Nat Genet 2012; 44:1365-1369
30. Gulsuner S, Walsh T, Watts AC, Lee MK, Thornton AM, Casadei S, Rippey C, Shahin H; Consortium on the Genetics of Schizophrenia (COGS); PAARTNERS Study Group, Nimgaonkar VL, Go RC, Savage RM, Swerdlow NR, Gur RE, Braff DL, King MC, McClellan JM: Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network. Cell 2013; 154:518-529
31. Shamir A, Buonanno A: Molecular and cellular characterization of Neuregulin-1 type IV isoforms. J Neurochem 2010; 113:1163-1176
32. Colantuoni C, Lipska BK, Ye T, Hyde TM, Tao R, Leek JT, Colantuoni EA, Elkahloun AG, Herman MM, Weinberger DR, Kleinman JE: Temporal dynamics and genetic control of transcription in the human prefrontal cortex. Nature 2011; 478:519-523
33. Harris LW, Lockstone HE, Khaitovich P, Weickert CS, Webster MJ, Bahn S: Gene expression in the prefrontal cortex during adolescence: implications for the onset of schizophrenia. BMC Med Genomics 2009; 2:28
34. Lipska BK, Deep-Soboslay A, Weickert CS, Hyde TM, Martin CE, Herman MM, Kleinman JE: Critical factors in gene expression in postmortem human brain: focus on studies in schizophrenia. Biol Psychiatry 2006; 60:650-658 (Pubitemid 44402385)
35. Kao WT, Wang Y, Kleinman JE, Lipska BK, Hyde TM, Weinberger DR, Law AJ: Common genetic variation in Neuregulin 3 (NRG3) influences risk for schizophrenia and impacts NRG3 expression in human brain. Proc Natl Acad Sci USA 2010; 107:15619-15624
36. Ozaki M, Itoh K, Miyakawa Y, Kishida H, Hashikawa T: Protein processing and releases of neuregulin-1 are regulated in an activity-dependent manner. J Neurochem 2004; 91:176-188 (Pubitemid 39314948)
37. Esper RM, Loeb JA: Neurotrophins induce neuregulin release through protein kinase Cd activation. J Biol Chem 2009; 284:26251-26260
38. Andersen SL: Trajectories of brain development: point of vulnerability or window of opportunity? Neurosci Biobehav Rev 2003; 27:3-18
39. Tau GZ, Peterson BS: Normal development of brain circuits. Neuropsychopharmacology 2010; 35:147-168
40. Brookman-Amissah N, Packer H, Prediger E, Sabel J: qPCR Application Guide: Experimental Overview, Protocol, Troubleshooting, 3rd ed. Coralville, Iowa, Integrated DNA Technologies, 2012 (https://eu.idtdna.com/Pages/docs/ catalog-product-documentation/primetime-qpcr-application-guide-3rd-ed-.pdf? sfvrsn=11)
41. Meyer D, Yamaai T, Garratt A, Riethmacher-Sonnenberg E, Kane D, Theill LE, Birchmeier C: Isoform-speci fic expression and function of neuregulin. Development 1997; 124:3575-3586 (Pubitemid 27470041)
42. López-Bendito G, Cautinat A, Sánchez JA, Bielle F, Flames N, Garratt AN, Talmage DA, Role LW, Charnay P, Marín O, Garel S: Tangential neuronal migration controls axon guidance: a role for neuregulin-1 in thalamocortical axon navigation. Cell 2006; 125:127-142
43. Jiang L, Emmetsberger J, Talmage DA, Role LW: Type III neuregulin 1 is required for multiple forms of excitatory synaptic plasticity of mouse cortico-amygdala circuits. J Neurosci 2013; 33:9655-9666
44. Luco RF, Allo M, Schor IE, Kornblihtt AR, Misteli T: Epigenetics in alternative pre-mRNA splicing. Cell 2011; 144:16-26
45. Weinberger DR: Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 1987; 44:660-669
46. Holmes WE, Sliwkowski MX, Akita RW, Henzel WJ, Lee J, Park JW, Yansura D, Abadi N, Raab H, Lewis GD, Shepard HM, Kuang W-J, Wood WI, Goeddel DV, Vandlen RL: Identification of heregulin, a specific activator of p185erbB2. Science 1992; 256:1205-1210
47. Wen D, Suggs SV, Karunagaran D, Liu N, Cupples RL, Luo Y, Janssen AM, Ben-Baruch N, Trollinger DB, Jacobsen VL: Structural and functional aspects of the multiplicity of Neu differentiation factors. Mol Cell Biol 1994; 14:1909-1919 (Pubitemid 24074586)
48. Zhang Z, Prentiss L, Heitzman D, Stahl RC, DiPino F Jr, Carey DJ: Neuregulin isoforms in dorsal root ganglion neurons: effects of the cytoplasmic domain on localization and membrane shedding of Nrg-1 type I. J Neurosci Res 2006; 84:1-12 (Pubitemid 44023058)
49. Liu X, Hwang H, Cao L, Wen D, Liu N, Graham RM, Zhou M: Release of the neuregulin functional polypeptide requires its cytoplasmic tail. J Biol Chem 1998; 273:34335-34340 (Pubitemid 29008911)
50. Bao J, Wolpowitz D, Role LW, Talmage DA: Back signaling by the Nrg-1 intracellular domain. J Cell Biol 2003; 161:1133-1141 (Pubitemid 36870174)
51. Golding M, Ruhrberg C, Sandle J, Gullick WJ: Mapping nucleolar and spliceosome localization sequences of neuregulin1-beta3. Exp Cell Res 2004; 299:110-118 (Pubitemid 39078386)